FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicolas Penel

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Antineoplastic Agents

Activities & Behaviors

Procedures

Co-author Network

Publications

TOP 3
Yves-Marie Robin; Philippe Terrier; Valérie Vélasco; Agnes Neuville; Nicolas Penel; Gaëlle Pérot; Dominique Ranchère-Vince; Jean-Michel Coindre
Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: a comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors.
Antoine Italiano; Marick Laë; Philippe Lagarde; Axel Le Cesne; Bernard Marques; Jean-Jacques Michels; Nicolas Penel; Sophie Piperno-Neumann; Dominique Ranchere-Vince; Philippe Terrier; Martine Trassard; Jacques-Olivier Bay; Jean-Yves Blay; Sylvie Bonvalot; Céline Brulard; Christine Chevreau; Angela Cioffi; Jean-Michel Coindre; Corinne Delcambre; Nicolas Isambert; Frédéric Chibon
Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics.
Nicolas Penel; M J Pontes; S Rodenhuis; P Schöffski; H J Schütte; J Verweij; M von Mehren; P Zintl; Jean-Yves Blay; P Casali; A Cassar; S P Chawla; S Cousin; G D Demetri; J Gomez; I Judson; ROBERT G MAKI; A Nieto; A Le Cesne
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicolas Penel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yves-Marie Robin; Philippe Terrier; Valérie Vélasco; Agnes Neuville; Nicolas Penel; Gaëlle Pérot; Dominique Ranchère-Vince; Jean-Michel Coindre
Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: a comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013;26(4):502-10.
2013: Antoine Italiano; Marick Laë; Philippe Lagarde; Axel Le Cesne; Bernard Marques; Jean-Jacques Michels; Nicolas Penel; Sophie Piperno-Neumann; Dominique Ranchere-Vince; Philippe Terrier; Martine Trassard; Jacques-Olivier Bay; Jean-Yves Blay; Sylvie Bonvalot; Céline Brulard; Christine Chevreau; Angela Cioffi; Jean-Michel Coindre; Corinne Delcambre; Nicolas Isambert; Frédéric Chibon
Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(5):1190-6.
2013: Nicolas Penel; M J Pontes; S Rodenhuis; P Schöffski; H J Schütte; J Verweij; M von Mehren; P Zintl; Jean-Yves Blay; P Casali; A Cassar; S P Chawla; S Cousin; G D Demetri; J Gomez; I Judson; ROBERT G MAKI; A Nieto; A Le Cesne
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(2):537-42.
2013: Jean-Yves Blay; Emmanuelle Bompas; Binh Bui; Philippe A Cassier; Loïc Chaigneau; Jean-Michel Coindre; Olivier Collard; Gauthier Decanter; Olfa Derbel; Florence Duffaud; Nicolas Isambert; Antoine Italiano; Axel Le Cesne; Nadia Badri; François Bertucci; ISABELLE RAY COQUARD; Maria Rios; Patrick Zintl; Nicolas Penel
Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program.
BMC cancer 2013;13():64.
2013: Clothilde Lindet; Jean-Jacques Michels; Agnès Neuville; Nicolas Penel; Yves-Marie Robin; Philippe Terrier; Martine Trassard; Isabelle Valo; Isabelle Birtwisle-Peyrottes; Marie-Christine Chateau; Françoise Collin; Marick Lae; Jean-Michel Coindre
Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO).
European journal of cancer (Oxford, England : 1990) 2013;49(2):369-76.
2012: Marie Vanhuyse; Laurent Zini; Marie Alt; A Caty; Ingrid Fumagalli; Nicolas Penel; Antoine Adenis
Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma?
Bulletin du cancer 2012;99(12):100-6.
2012: Nicolas Penel; Antoine Adenis; Jacques Bonneterre
Role of the investigator in phase 1 trials of anticancer drugs.
The lancet oncology 2012;13(12):1177-9.
2012: Antoine Adenis; Jacques-Olivier Bay; François Bertucci; Jean-Yves Blay; Olivier Bouché; Philippe Cassier; Christine Chevreau; Stéphanie Clisant; Olivier Collard; Charles Fournier; Antoine Italiano; Elsa Kalbacher; Andrew Kramar; Nicolas Penel
Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.
Medical oncology (Northwood, London, England) 2012;29(4):3003-8.
2012: Eric Yaovi Amela; Sophie Cousin; Géraldine Lauridant-Philippin; Antoine Adenis; Thomas Ryckewaert; Nicolas Penel
Management of "unfavourable" carcinoma of unknown primary site: synthesis of recent literature.
Critical reviews in oncology/hematology 2012;84(2):213-23.
2012: A Ploquin; J H Schellens; P Schöffski; J-C Soria; C Twelves; J Verweij; E E Voest; R A'Hern; Hendrik-Tobias Arkenau; A Duhamel; S B Kaye; A Kramar; R S Kristeleit; D Lacombe; Silvia Marsoni; R Morales-Barrera; DAVID oLMOS; Nicolas Penel
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin.
British journal of cancer 2012;107(7):1025-30.
2012: Anne Ploquin; Philippe A Cassier; Alain Duhamel; Charles Ferté; Andrew Kramar; David Olmos; Nicolas Penel
Life-expectancy of patients enrolled in phase 1 clinical trials: a systematic review of published prognostic models.
Critical reviews in oncology/hematology 2012;83(2):242-8.
2012: Antoine Italiano; Elsa Kalbacher; Matteo Giaj Levra; ROBERT G MAKI; Nicolas Penel; Cristina Antonescu; François Bertucci; Jean-Yves Blay; Binh Bui; Christine Chevreau; Angela Cioffi; David R D'Adamo; Corinne Delcambre; Nicolas Isambert; Mary-Louise Keohan
Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.
Cancer 2012;118(13):3330-6.
2012: A Italiano; Axel Le Cesne; B Lortal; ROBERT G MAKI; Anna Patrikidou; Nicolas Penel; G K Schwartz; S Singer; M Toulmonde; Cristina R Antonescu; Jean-Yves Blay; Emmanuelle Bompas; Angela Cioffi; Jean-Michel Coindre; Florence Duffaud; N Isambert; Binh Nguyen Bui
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(6):1601-7.
2012: Sophie Cousin; Sophie Taieb; Nicolas Penel
A paradigm shift in tumour response evaluation of targeted therapy: the assessment of novel drugs in exploratory clinical trials.
Current opinion in oncology 2012;24(3):338-44.
2012: Stéphanie Clisant; Antoine Adenis; Aurélie Clermont; Nicolas Penel
Inflation in the number of eligibility criteria for industry-sponsored phase II cancer clinical trial: illustration over a 20-year period.
Contemporary clinical trials 2012;33(3):459.
2012: Nicolas Penel; Antoine Adenis; Guido Bocci
Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?
Critical reviews in oncology/hematology 2012;82(1):40-50.
2012: Nicolas Penel; Antoine Adenis; Stéphanie Clisant; Patrick Devos; Alain Duhamel; Nicolas Isambert; Jacques Bonneterre
Predictors for establishing recommended phase 2 doses: analysis of 320 dose-seeking oncology phase 1 trials.
Investigational new drugs 2012;30(2):653-61.
2012: Lydie Declerck; Antoine Adenis; Claude Adenis; Eric Amela; A Caty; Nicolas Penel
Prostate cancer related haemophagocytic syndrome: successful treatment with chemotherapy.
Acta oncologica (Stockholm, Sweden) 2012;51(2):268-9.
2012: Nicolas Penel; ISABELLE RAY COQUARD; Y M Robin; Jacques-Olivier Bay; F Bertucci; Jean-Yves Blay; Emmanuelle Bompas; Binh Nguyen Bui; Loïc Chaigneau; Didier Cupissol; C Delcambre; F Duffaud; C Guillemet; N Isambert; A Italiano
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(2):517-23.
2012: Nuria Kotecki; Nicolas Penel; Antoine Adenis; Charles Ferte; Stéphanie Clisant
Predictive value of clinical judgment of tumour progression in phase II trials.
PloS one 2012;7(12):e52638.
2012: Patricia Pautier; Nicolas Penel; Sophie Piperno-Neumann; Annie Rey; Jean-Yves Blay; Emmanuelle Bompas; Angela Cioffi; Françoise Collin; Didier Cupissol; Corinne Delcambre; Anne Floquet; Nicolas Isambert; Marta Jimenez; Florence Duffaud
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study).
The oncologist 2012;17(9):1213-20.
2012: Nicolas Penel; Andrew Kramar
What does a modified-Fibonacci dose-escalation actually correspond to?
BMC medical research methodology 2012;12():103.
2012: Nicolas Penel; Yves-Marie Robin; Eric Yaovi Amela; Gauthier Decanter; Perrine Marec-Berard
Solitary fibrous tumors and so-called hemangiopericytoma.
Sarcoma 2012;2012():690251.
2012: ISABELLE RAY COQUARD; Yves-Marie Robin; Jacques-Olivier Bay; Jean-Yves Blay; Emmanuelle Bompas; Guilhem Bousquet; Christine Chevreau; Stéphanie Clisant; Olivier Collard; Didier Cupissol; Charles Fournier; Eric Gauthier; Nicolas Isambert; Antoine Italiano; Axel Le Cesne; Laurent Lemaitre; Nicolas Penel; Sophie Piperno-Neumann
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).
The oncologist 2012;17(2):260-6.
2011: Nicolas Penel; Stéphanie Clisant; Antoine Adenis; Jacques Bonneterre
Nature and subjectivity of dose-limiting toxicities in contemporary phase 1 trials: comparison of cytotoxic versus non-cytotoxic drugs.
Investigational new drugs 2011;29(6):1414-9.
2011: Emeline Pape; Nicolas Penel; Nicolas Rezvoy; Julia Salleron; Sophie Darras; Veronique Dziwniel; Pierre Guerreschi; Veronique Martinot; Xavier Mirabel; Laurent Mortier
Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients.
Journal of the American Academy of Dermatology 2011;65(5):983-90.
2011: Claire Vautravers-Dewas; Nicolas Penel; Antoine Adenis; F Bonodeau; Sylvain Dewas; Thomas Lacornerie; Eric Lartigau; Xavier Mirabel
Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship?
International journal of radiation oncology, biology, physics 2011;81(3):e39-47.
2011: Nicolas Penel; Yves-Marie Robin; Sandrine Marréaud; Peter Hohenberger
Angiosarcoma: state of the art and perspectives.
Critical reviews in oncology/hematology 2011;80(2):257-63.
2011: Nicolas Penel; Charles Fournier; Jocelyne Bérille
Proposal for size justification of expanded cohort at phase-2-recommended dose.
Investigational new drugs 2011;29(4):713-5.
2011: Tanguy Leroy; Véronique Christophe; Nicolas Penel; Pascal Antoine; Stéphanie Clisant
Factual understanding of randomized clinical trials: a multicenter case-control study in cancer patients.
Investigational new drugs 2011;29(4):700-5.
2011: Mélanie Morel; Sophie Taïeb; Nicolas Penel; Laurent Mortier; Luc Vanseymortier; Y Marie Robin; Pierre Gosset; Anne Cotten; Luc Ceugnart
Imaging of the most frequent superficial soft-tissue sarcomas.
Skeletal radiology 2011;40(3):271-84.
2011: Charles Ferte; Jean-Charles Soria; Nicolas Penel
Dose-levels and first signs of efficacy in contemporary oncology phase 1 clinical trials.
PloS one 2011;6(3):e16633.
2011: Jean-Emmanuel Bibault; Sylvain Dewas; Xavier Mirabel; Laurent Mortier; Nicolas Penel; Luc Vanseymortier; Eric Lartigau
Adjuvant radiation therapy in metastatic lymph nodes from melanoma.
Radiation oncology (London, England) 2011;6():12.
2011: Tanguy Leroy; Véronique Christophe; Nicolas Penel; Stéphanie Clisant; Pascal Antoine
Participation in randomised clinical trials is linked to emotion regulation strategies.
Contemporary clinical trials 2011;32(1):32-5.
2010: Nicolas Penel; Pierre Leblond; Amélie Lansiaux; Stéphanie Clisant; Eric Dansin; Antoine Adenis; Jacques Bonneterre
Justification of the starting dose as the main determinant of accrual time in dose-seeking oncology phase 1 trials.
Investigational new drugs 2010;28(6):839-43.
2010: Nicolas Penel; Antoine Adenis; A Mailliez; Jacques Bonneterre
Silent hereditary hematochromatosis as a susceptibility factor of doxorubicin-induced acute cardiac failure.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(11):2293-4.
2010: Estelle Borne; Eve Desmedt; Alain Duhamel; Xavier Mirabel; Véronique Dziwniel; Cyril Maire; Valérie Florin; Véronique Martinot; Nicolas Penel; Sophie Vercambre-Darras; Laurent Mortier
Oral metronomic cyclophosphamide in elderly with metastatic melanoma.
Investigational new drugs 2010;28(5):684-9.
2010: Sylvia Giard; M-P Chauvet; Nicolas Penel; H Mignotte; P Martel; C Tunon de Lara; P Gimbergues; P Dessogne; J-M Classe; Eric Fondrinier; T Marmousez
Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a French prospective multi-institutional study (IGASSU 0502).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(8):1630-5.
2010: Antoine Hollebecque; Antoine Adenis; Sophie Taieb; Claudia Lebedinsky; Nicolas Penel
Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients.
Investigational new drugs 2010;28(4):529-30.
2010: Nicolas Penel; A Italiano; N Isambert; Emmanuelle Bompas; G Bousquet; F Duffaud
Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(6):1361-5.
2010: Nicolas Penel; Stéphanie Clisant; E Dansin; C Desauw; M Dégardin; L Mortier; M Vanhuyse; F Bonodeau; Charles Fournier; J-L Cazin; Antoine Adenis
Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care.
British journal of cancer 2010;102(8):1207-12.
2010: Antoine Adenis; Charles Ferté; Nicolas Penel
Phase II trials in patients with carcinoma of unknown primary: a pooled data analysis.
Investigational new drugs 2010;28(2):178-84.
2010: Pedro Ricardo Milet; Yann Mallet; Sophie El Bedoui; Nicolas Penel; Véronique Servent; Jean-Louis Lefebvre
Head and neck cancer surgery in the elderly--does age influence the postoperative course?
Oral oncology 2010;46(2):92-5.
2010: Nicolas Penel; Jean-Pierre Delord; Marie-Edith Bonneterre; Thomas Bachelot; ISABELLE RAY COQUARD; Jean-Yves Blay; Laurent Benjamin Pascal; Cécile Borel; Thomas Filleron; Antoine Adenis; Jacques Bonneterre
Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics.
Investigational new drugs 2010;28(1):76-82.
2010: Charles Ferté; Nicolas Penel; Jacques Bonneterre; Antoine Adenis
Individual life expectancy estimation using validated prognostic scores for patients with cancer of unknown primary.
Oncology 2010;78(2):87-93.
2010: Nicolas Penel; Charles Fournier; C Stéphanie
[Phases 0, 1 and 2 oncology clinical trials: current questions].
Bulletin du cancer 2010;97(1):55-63.
2009: Nicolas Penel; Mélanie Morel
[Primary and secondary bone tumors].
La Revue du praticien 2009;59(10):1427-34.
2009: Yann Mallet; S El Bedoui; Nicolas Penel; Jean Ton Van; Charles Fournier; Jean-Louis Lefebvre
The free vascularized flap and the pectoralis major pedicled flap options: comparative results of reconstruction of the tongue.
Oral oncology 2009;45(12):1028-31.
2009: Nicolas Penel; Alain Duhamel; Charles Ferte; Nicolas Isambert; Pierre Leblond; Jacques Bonneterre
"Classical 3 + 3 design" versus "accelerated titration designs": analysis of 270 phase 1 trials investigating anti-cancer agents.
Investigational new drugs 2009;27(6):552-6.
2009: Sophie Taïeb; Nicolas Penel; Luc Vanseymortier; Luc Ceugnart
Soft tissue sarcomas or intramuscular haematomas?
European journal of radiology 2009;72(1):44-9.
2009: Nicolas Penel; Sylvain Dewas; Aurélien Hoffman; Antoine Adenis
Cancer-associated hypercalcemia: validation of a bedside prognostic score.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009;17(8):1133-5.
2009: C Ferté; A Hollebecque; J Salleron; Nicolas Penel
[Clinical equipoise and randomised clinical trials in oncology].
Bulletin du cancer 2009;96(6):727-31.
2009: C Ferté; L B Pascal; Nicolas Penel
[Prognostic and predictive factors of soft tissue sarcoma: a daily use of translational research].
Bulletin du cancer 2009;96(4):451-60.
2009: Nicolas Penel; Yazdan Yazdanpanah
Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysis.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009;17(3):285-93.
2009: Antoine Adenis; Nicolas Penel; Jean-Yves Blay
Imatinib in gastrointestinal stromal tumor: does treatment duration matter?
Oncology 2009;77(3-4):157-61.
2009: Nicolas Penel; Sylvie Negrier; ISABELLE RAY COQUARD; Charles Ferte; Patrick Devos; Antoine Hollebecque; Michael B Sawyer; Antoine Adenis; Pascal Seve
Development and validation of a bedside score to predict early death in cancer of unknown primary patients.
PloS one 2009;4(8):e6483.
2008: Nicolas Penel; Corinne Delcambre; Xavier Durando; Stéphanie Clisant; Mohamed Hebbar; Sylvie Negrier; Charles Fournier; Nicolas Isambert; Frédéric Mascarelli; Frédéric Mouriaux
O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma.
Investigational new drugs 2008;26(6):561-5.
2008: Nicolas Penel; Binh Nguyen Bui; Jacques-Olivier Bay; Didier Cupissol; ISABELLE RAY COQUARD; Sophie Piperno-Neumann; Pierre Kerbrat; Charles Fournier; Sophie Taieb; Marta Jimenez; Nicolas Isambert; Frédéric Peyrade; Christine Chevreau; Emmanuelle Bompas; Etienne G C Brain; Jean-Yves Blay
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5269-74.
2008: Nicolas Penel; Antoine Hollebecque; Carlos Maynou; Jérôme Dewaele; Marie Jasserand; Régis Beuscart; Marie-Hélène Vieillard
Development of a score that predicts survival among patients with bone metastasis revealing solid tumor.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(9):1089-93.
2008: Nicolas Penel; Yann Mallet; Micheline Roussel-Delvallez; Jean-Louis Lefebvre; Yazdan Yazdanpanah
Factors determining length of the postoperative hospital stay after major head and neck cancer surgery.
Oral oncology 2008;44(6):555-62.
2008: Nicolas Penel; Y Mallet; Y-M Robin; Charles Fournier; J Grosjean; L Ceugnart; Stéphanie Clisant; Jean-Louis Lefebvre
Prognostic factors for adult sarcomas of head and neck.
International journal of oral and maxillofacial surgery 2008;37(5):428-32.
2008: Nicolas Penel; Sylvain Dewas; Philippe Doutrelant; Stéphanie Clisant; Yazdan Yazdanpanah; Antoine Adenis
Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(4):387-92.
2008: Nicolas Penel; Julia Saleron; Amélie Lansiaux; Stéphanie Clisant; Antoine Adenis; Charles Fournier; Alain Duhamel; Jacques Bonneterre
[Methodological approaches of clinical studies with targeted therapies].
Bulletin du cancer 2008;95(2):185-90.
2008: Nicolas Penel; Jean-Louis Lefebvre; J L Cazin; Stéphanie Clisant; Jean-Charles Neu; B Dervaux; Yazdan Yazdanpanah
Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis.
International journal of oral and maxillofacial surgery 2008;37(2):135-9.
2008: Nicolas Penel; Marie Vanseymortier; Marie-Edith Bonneterre; Stéphanie Clisant; Eric Dansin; Yvette Vendel; Régis Beuscart; Jacques Bonneterre
Prognostic factors among cancer patients with good performance status screened for phase I trials.
Investigational new drugs 2008;26(1):53-8.
2008: Nicolas Penel; Jessica Grosjean; Yves Marie Robin; Luc Vanseymortier; Stéphanie Clisant; Antoine Adenis
Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases.
Sarcoma 2008;2008():459386.
2007: Nicolas Penel; Amélie Lansiaux; Antoine Adenis
Angiosarcomas and taxanes.
Current treatment options in oncology 2007;8(6):428-34.
2007: Nicolas Penel; François Valentin; Sandrine Giscard; Luc Vanseymortier; Régis Beuscart
General practitioners assessment of a structured report on medical decision making by a regional multidisciplinary cancer committee.
Bulletin du cancer 2007;94(10):E23-6.
2007: Nicolas Penel; Jean-Charles Neu; Stéphanie Clisant; Helga Hoppe; Patrick Devos; Yazdan Yazdanpanah
Risk factors for early catheter-related infections in cancer patients.
Cancer 2007;110(7):1586-92.
2007: Nicolas Penel; Eric Yaovi Amela; Yann Mallet; Danièle Lefebvre; Stéphanie Clisant; Ahmed Kara; Jean-Charles Neu; Frédéric Everard; Jean-Louis Lefebvre
A simple predictive model for postoperative mortality after head and neck cancer surgery with opening of mucosa.
Oral oncology 2007;43(2):174-80.
2007: Nicolas Penel; Damien Vansteene
[Cancers and pesticides: current data].
Bulletin du cancer 2007;94(1):15-22.
2006: Sophie Taieb; Nicolas Penel; Luc Ceugnart
[Interest of imaging for the monitoring of a treated cancer: simplified use of likelyhood ratio. The example of soft tissue tumor].
Bulletin du cancer 2006;93(12):1201-6.
2006: Nicolas Penel; Yann Mallet; Xavier Mirabel; Jean Ton Van; Jean-Louis Lefebvre
Primary mucosal melanoma of head and neck: prognostic value of clear margins.
The Laryngoscope 2006;116(6):993-5.
2006: Sophie Taieb; Luc Ceugnart; Hélène Gauthier; Nicolas Penel; Luc Vanseymortier
[Soft sarcoma tissue of extremities: medical imagery in post-therapeutic follow-up].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2006;10(1-2):78-82.
2006: Sophie Taieb; Luc Ceugnart; Hélène Gauthier; Nicolas Penel; Luc Vanseymortier
[Soft tissue sarcoma: role of imaging for initial diagnosis and treatment].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2006;10(1-2):22-33.
2005: N Goulois; Céline Berthon; Luc Vanseymortier; Nicolas Penel
[Soft tissue sarcoma associated with chronic lymphocytic leukemia: about 5 cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2005;26(12):990-2.
2005: Nicolas Penel; Céline Berthon; Frédéric Everard; Jean-Charles Neu; Stéphanie Clisant; Michèle N'Guyen; Stéphanie Villet; Charles Fournier; Jean-Louis Lefebvre
Prognosis of hypercalcemia in aerodigestive tract cancers: study of 136 recent cases.
Oral oncology 2005;41(9):884-9.
2005: Nicolas Penel; Céline Berthon; A Kara; Luc Vanseymortier; A Adenis
[Association soft tissue sarcoma and familial adenomatous polyposis: a case-report].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2005;26(7):596-7.
2005: Olivier Rozniatowski; Michel Reich; Yann Mallet; Nicolas Penel; Charles Fournier; Jean-Louis Lefebvre
Psychosocial factors involved in delayed consultation by patients with head and neck cancer.
Head & neck 2005;27(4):274-80.
2005: Nicolas Penel; Charles Fournier; Danièle Lefebvre; Jean-Louis Lefebvre
Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures.
Oral oncology 2005;41(3):294-303.
2004: C Leclercq; Nicolas Penel; J Grosjean; Charles Fournier; Marie-Odile Vilain; D Pasquier; Luc Ceugnart; Luc Vanseymortier
[Prognosis of post-irradiation soft-tissue sarcoma: case-control study].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2004;25(12):866-71.
2004: Nicolas Penel; Christophe Van Haverbeke; Eric Lartigau; Marie-Odile Vilain; Jean Ton Van; Yann Mallet; Jean-Louis Lefebvre
Head and neck soft tissue sarcomas of adult: prognostic value of surgery in multimodal therapeutic approach.
Oral oncology 2004;40(9):890-7.
2004: Nicolas Penel; Charles Fournier; Micheline Roussel-Delvallez; Danièle Lefebvre; Ahmed Kara; Yann Mallet; Jean-Charles Neu; Jean-Louis Lefebvre
Prognostic significance of wound infections following major head and neck cancer surgery: an open non-comparative prospective study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2004;12(9):634-9.
2004: Nicolas Penel; Charles Fournier; Stéphanie Clisant; Michèle N'Guyen
Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2004;12(8):593-8.
2004: Nicolas Penel; Charles Fournier; Danièle Lefebvre; Micheline Roussel-Delvallez; Jérôme Sarini; Ahmed Kara; Yann Mallet; Jean-Louis Lefebvre
Previous chemotherapy as a predictor of wound infections in nonmajor head and neck surgery: Results of a prospective study.
Head & neck 2004;26(6):513-7.
2004: Nicolas Penel; Charles Fournier; Sylvia Giard; Danièle Lefebvres
[A prospective evaluation of antibiotic prophylaxis efficacy for breast cancer surgery following previous chemotherapy].
Bulletin du cancer 2004;91(5):445-8.
2004: J Grosjean; Nicolas Penel; Hélène Gauthier; Luc Vanseymortier
[Ultra-late metastasis of ocular melanoma: about two cases].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2004;25(2):147-9.
2003: Nicolas Penel; Charles Fournier; Micheline Roussel-Delvallez; M-F Deberles; E Buisset; J-L Cazin; B Leclercq
[Analysis of the factors influencing the internal reporting of nosocomial infections. A review of 108 notifications].
Presse médicale (Paris, France : 1983) 2003;32(38):1797-801.
2003: Nicolas Penel; Gérard Depadt; Marie-Odile Vilain; Luc Vanseymortier; Luc Ceugnart; Sophie Taieb; Xavier Mirabel; Nathalie Deligny; Annick Chevalier; Marie-Christine Baranzelli; Fabienne Pichon; Dominique Hoguet; Yves-Marie Robin; Eric Lartigau
[Frequency of genetic diseases and cancer antecedents in 493 adults with visceral or soft tissue sarcomas].
Bulletin du cancer 2003;90(10):887-95.
2003: Nicolas Penel; J Bonneterre
[Gene therapy of melanoma: review of published clinical trials].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2003;24(7):443-51.
2003: Nicolas Penel
[Prognosis and possibilities of treatment of inaugural metastases].
Presse médicale (Paris, France : 1983) 2003;32(21):997-1004.
2003: Nicolas Penel
[Diagnostic management of inaugurable metastases].
Presse médicale (Paris, France : 1983) 2003;32(21):990-6, 1004.
2003: Nicolas Penel; Eric Lartigau; Charles Fournier; Marie-Odile Vilain; E Dansin; Sophie Taieb; Luc Ceugnart; Henri Porte; Alain Wurtz
[Primary soft tissue sarcoma of the chest in adults: a retrospective study of 40 cases].
Annales de chirurgie 2003;128(4):237-45.
2003: V Lecoeuvre; M Degardin; Nicolas Penel; J Grosjean; F Bonodeau
[Renal colic due to kidney metastase from larynx cancer].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2003;24(1):67-9.
2003: V Lecoeuvre; Nicolas Penel; D Grandmougin; Sophie Taieb; S Aubert; Eric Lartigau
[Primary leiomyosarcoma of pulmonary artery: a rare tumor mis-diagnosed as pulmonary embolism].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2003;24(1):45-8.
2002: Jérôme Sarini; Corso Bocciolini; Charles Fournier; Nicolas Penel; Ahmed Kara; Jean Ton Van; Jean-Louis Lefebvre
[Induction chemotherapy and larynx preservation: is such practice useful?].
Bulletin du cancer 2002;89(4):411-7.
2002: Nicolas Penel; H Kouto; C Ala-Eddine; M Degardin
[Tumor lysis syndrome with symptomatic hyperuricemia after a first chemotherapeutic treatment of undifferentiated carcinoma of the cavum].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2002;23(3):337-9.
2001: Nicolas Penel; C Nisse; S Feddal; Eric Lartigau
[Epidemiology of soft tissue sarcomas in adults].
Presse médicale (Paris, France : 1983) 2001;30(28):1405-13.
2001: Eric Lartigau; Guy Kantor; Sophie Taieb; Marie-Odile Vilain; Luc Ceugnart; Philippe Lagarde; Nicolas Penel; Gérard Depadt
[Definitions of target volumes in soft tissue sarcomas of the extremities].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2001;5(5):695-703.
2001: Nicolas Penel; Charles Fournier; M Degardin; H Kouto; Michèle N'Guyen
[Fever and solid tumor: diagnostic value of procalcitonin and C-reactive protein].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2001;22(8):706-14.
2001: Nicolas Penel; Danièle Lefebvre; Charles Fournier; Jérôme Sarini; Ahmed Kara; Jean-Louis Lefebvre
Risk factors for wound infection in head and neck cancer surgery: a prospective study.
Head & neck 2001;23(6):447-55.
2001: Nicolas Penel; Charles Fournier; Ahmed Kara; Jérôme Sarini; Danièle Lefebvre
[Anticancer chemotherapy, risk factor for infection at the operated site in cervicofacial surgery].
Presse médicale (Paris, France : 1983) 2001;30(18):892-5.
2001: Nicolas Penel; A L Ulazewski; M Reich
[The reality of disease: the testimony of Arthur and Isabelle Rimbaud].
Presse médicale (Paris, France : 1983) 2001;30(13):636-8.
2000: Danièle Lefebvre; Nicolas Penel; M F Deberles; Charles Fournier
[Incidence and surgical wound infection risk factors in breast cancer surgery].
Presse médicale (Paris, France : 1983) 2000;29(35):1927-32.
2000: Nicolas Penel; M Degardin; F Frippiat; E Hachulla
[Are there criteria for the diagnosis of paraneoplastic fever?].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2000;21(8):684-92.
1999: Nicolas Penel; Danièle Lefebvre; Jean-Louis Lefebvre
[Wound infection in head and neck cancer surgery].
Bulletin du cancer 1999;86(12):985-95.